AGA
AMGN icon

Accuvest Global Advisors’s Amgen AMGN Stock Holding History

Accuvest Global Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-54
Closed -$13K – 48
2019
Q4 		$13K Buy
+54
New +$11.9K 0.03% 41
2019
Q3 		– Sell
-1,643
Closed -$303K – 71
2019
Q2 		$303K Buy
+1,643
New +$294K 0.18% 92
2018
Q4 		– Sell
-1,892
Closed -$392K – 112
2018
Q3 		$392K Buy
+1,892
New +$373K 0.15% 109

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Accuvest Global Advisors's AMGN Position: Q1 2020 in Review

Accuvest Global Advisors sold out of Amgen (AMGN) in Q1 2020, closing a stake of 54 shares — an estimated $13K sold.

Accuvest Global Advisors first reported a position in AMGN in Q3 2018 and held it in 3 quarters. The position peaked at $392K in Q3 2018. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Accuvest Global Advisors reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • Accuvest Global Advisors sold 54 Amgen shares in Q1 2020, an estimated $13K.
  • Accuvest Global Advisors first reported a position in Amgen in Q3 2018 and held it in 3 quarters.
  • Accuvest Global Advisors's Amgen position peaked at $392K in Q3 2018.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Accuvest Global Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.